Form D · Investing
Vaccinium (USA) LLC
Northamptonshire, X0 · CIK 0001649361
Offering snapshot reported Jul 29, 2015 · SEC filing
- Reported sold
- $300K Offering amount: $5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $60K Reported outside-investor minimum
- First sale
- Jul 15, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 29, 2015 | Initial | $300,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-244709
Membership interests in limited liability company
Source: Form D, filed Jul 29, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Garner | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
298 Wellingborough Road Northampton
Northamptonshire, X0, NN1 4EP
Northamptonshire, X0, NN1 4EP